Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arul Mahadevan

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Urologic Oncology|December 30, 2008
Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?Eric A Klein, Jay Ciezki, Patrick A Kupelian, et al.
Surgical Innovation|January 8, 2008
Renal radiosurgery: initial clinical experience with histological evaluationLee E Ponsky, Arul Mahadevan, Indebir S Gill, et al.
Cancer|March 17, 2004
Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?Deepak Khuntia, Chandana A Reddy, Arul Mahadevan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2007
Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancerPatrick A Kupelian, Jay Ciezki, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experiencePatrick A Kupelian, Twyla R Willoughby, Chandana A Reddy, et al.
Urology|September 19, 2006
Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancerPatrick A Kupelian, Arul Mahadevan, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2007
Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancerPatrick A Kupelian, Twyla R Willoughby, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomesPatrick A Kupelian, Vipul V Thakkar, Deepak Khuntia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Aggressiveness of familial prostate cancerPatrick A Kupelian, Chandana A Reddy, Alwyn M Reuther, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomyJay P Ciezki, Eric A Klein, Kenneth Angermeier, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Urologic Oncology|December 30, 2008
Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?Eric A Klein, Jay Ciezki, Patrick A Kupelian, et al.
Surgical Innovation|January 8, 2008
Renal radiosurgery: initial clinical experience with histological evaluationLee E Ponsky, Arul Mahadevan, Indebir S Gill, et al.
Cancer|March 17, 2004
Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?Deepak Khuntia, Chandana A Reddy, Arul Mahadevan, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2007
Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancerPatrick A Kupelian, Jay Ciezki, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experiencePatrick A Kupelian, Twyla R Willoughby, Chandana A Reddy, et al.
Urology|September 19, 2006
Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancerPatrick A Kupelian, Arul Mahadevan, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2007
Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancerPatrick A Kupelian, Twyla R Willoughby, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomesPatrick A Kupelian, Vipul V Thakkar, Deepak Khuntia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
Aggressiveness of familial prostate cancerPatrick A Kupelian, Chandana A Reddy, Alwyn M Reuther, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomyJay P Ciezki, Eric A Klein, Kenneth Angermeier, et al.
Pageof 3